2021-07-21 10:42 Parkinson’s disease (PD) is a type of disease in the nervous system that is second only to Alzheimer’s disease, and sometimes it is difficult to distinguish it from other neurodegenerative diseases in diagnosis. The development and research of biomar ... дальше
2021-06-27 21:17 Our cutting-edge Native™ Antibody discovery, Hyperdoma™ and Phage Display platforms allow the production of the most comprehensive list of virology recombinant antibody products. Our antibody products range from research use only antibody, diagnostic ... дальше
2021-05-19 10:48 A class of disease that affects the lungs and other parts of the respiratory system. Currently, World Health Organisation estimates indicate that 235 million people worldwide suffer with asthma, 64 million with chronic obstructive pulmonary disease ( ... дальше
2021-05-19 10:46 In general, the main challenges in creating and implementing orphan drugs result from the rarity, heterogeneity and the complex patient management inherently in rare conditions. CD BioSciences' clinical trial development service is your preferred rar ... дальше
2021-04-22 21:09 CD BioSciences provides fully integrated clinical services for musculoskeletal research. Our well-trained professionals have extensive experience in the field of musculoskeletal research, who can accurately and effectively assess the effects of muscu ... дальше
2021-04-02 06:27 CD BioSciences provides fully integrated clinical services for musculoskeletal research. Our well-trained professionals have extensive experience in the field of musculoskeletal research, who can accurately and effectively assess the effects of muscu ... дальше
2020-10-31 15:55 Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by age-related amyloid-beta (Aβ) deposition neurofibrillary tangles, and synapse and neuronal loss. Currently, only few drugs have been approved for the treatment of AD and ... дальше
2020-08-17 19:45 Parkinson's disease (PD) is a neurodegenerative disorder that affects about 1.5% of the global population over 65 years of age. Robust, well-validated pre-clinical models of PD are valuable tools for understanding the biology and possible treatment o ... дальше
2020-07-13 11:12 Parkinson’s disease (PD) is a type of disease in the nervous system that is second only to Alzheimer’s disease, and sometimes it is difficult to distinguish it from other neurodegenerative diseases in diagnosis. The development and research of biomar ... дальше
2020-07-13 11:11 The complexity and diversity of Alzheimer’s disease (AD) make it difficult to diagnose accurately. The use of biomarkers can promote the improvement of the diagnostic effectiveness and sensitivity of AD. Creative BioMart Biomarker is one of the exper ... дальше